When a deadly listeria outbreak swept across Canada in 2024, the initial headlines focused on recalls and rising case counts.
Natera delivers robust revenue growth, raising 2026 guidance to $2.74–$2.82 billion, but remains unprofitable. Read more on NTRA stock here.
Interferon receptor knockout chickens uncover how type I and III interferons differentially shape avian antiviral immunity and influenza disease outcomes.
Sequence alignment and genetic variation calling To detect SNPs in populations, raw reads of DNA were filtered to remove sequencing adapters and low-quality bases using fastp (v.0.12.2) with the ...